Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Repligen Corporation

RGEN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$137.22
$0.00(0.00%)
U.S. Market is Open • 12:49

Repligen Corporation (RGEN) Stock Overview

Explore Repligen Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.6B
P/E Ratio4414.17
EPS (TTM)$0.01
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$137.78
3 Months$142.10
1 Year Target$120.85

RGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Repligen Corporation (RGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.52, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $120.85.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 4414.17 and a market capitalization of 7.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.12%
5-Day Change
1.28%
1-Month Change
-16.93%
3-Month Change
-12.10%
6-Month Change
11.62%
Year-to-Date (YTD) Change
-17.44%
1-Year Change
-16.59%
3-Year Change
-23.78%
5-Year Change
-35.63%
All-Time (Max) Change
1106.04%

Contact Information

https://www.repligen.com
781 250 0111
Building 1, Waltham, MA, 02453

Company Facts

17,780 Employees
IPO DateApr 29, 1986
CountryUS
Actively Trading

Frequently Asked Questions